glp-1 meds for weight loss Comparing Ozempic, Wegovy and Other Drugs How GLP-1 medications are transforming

PAD is risky Just like arteries of the heart, the walls of arteries elsewhere in the body - typically in the legs, but also in the arms or abdomen - can become stuffed with fatty deposits and plaque, a condition called atherosclerosis

Chronic sleep deprivation (less than 67 hours nightly) disrupts appetite-regulating hormones, increases cortisol levels, and promotes insulin resistance

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become essential medications in the management of type 2 diabetes mellitus and obesity due to their ability to improve glucose control and facilitate weight loss by enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying

It is important to keep in mind that people taking GLP-1 medications may already be at risk of developing SIBO for other reasons

[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Michos ED, Bakris GL, Rodbard HW, Tuttle KR